Eton Pharmaceuticals, Inc. ETON Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s increase (decrease) in other noncurrent assets and liabilities, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s increase (decrease) in other noncurrent assets and liabilities, net?
- Eton Pharmaceuticals, Inc. (ETON) reported increase (decrease) in other noncurrent assets and liabilities, net of $1.82M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s increase (decrease) in other noncurrent assets and liabilities, net changed year-over-year?
- Eton Pharmaceuticals, Inc.'s increase (decrease) in other noncurrent assets and liabilities, net increased by 183.0% year-over-year, from -$2.19M to $1.82M.
- What does increase (decrease) in other noncurrent assets and liabilities, net mean?
- Captures the net change in long-term assets and liabilities that do not fall into standard operating categories. This aggregate figure reflects shifts in long-term deferred items, non-current deposits, or other miscellaneous long-term obligations. It provides insight into the company's long-term balance sheet management and non-operating cash flow drivers.